Myburgh & Co launches peptide serum aimed at retinol alternatives
Australian skincare brand Myburgh & Co has launched GLOW Advanced Peptide Serum in Gold Coast, Queensland, positioning GHK-Cu and SNAP-8 as an option for women seeking anti-ageing results without retinol’s common irritation. The 40 mL serum is priced at A$129 and is now available online.
Why it matters: - Myburgh & Co is targeting a growing skincare segment: women looking for anti-ageing ingredients that may be easier to tolerate than retinol. - The launch reflects wider interest in peptide-based formulas for visible concerns such as fine lines, firmness and skin texture. - The product sits in the premium skincare category, with a recommended retail price of A$129 for 40 mL.
What happened: - Myburgh & Co launched GLOW Advanced Peptide Serum in Gold Coast, Queensland, Australia, on October 21, 2026. - The serum combines GHK-Cu, also called Copper Tripeptide-1, with SNAP-8, also called Acetyl Octapeptide-3. - The brand positioned the serum as an advanced peptide alternative for women exploring skincare beyond traditional retinol. - The product is available through the company's website: more information.
The details: - GHK-Cu has been studied for its potential relationship with collagen production, skin structure and natural renewal processes. - SNAP-8 is a cosmetic peptide used in formulations aimed at the appearance of expression lines, especially around the eyes and forehead. - Myburgh & Co says GLOW also includes a multi-peptide complex and complementary skincare ingredients. - The brand says the serum is designed to support smoother-looking skin and improved texture. - The formula is also intended to support firmer, more supple-looking skin as part of a daily routine. - Myburgh & Co says the serum is designed to soften the appearance of fine lines and visible signs of ageing. - The brand says the product aims to support a healthier, more radiant complexion. - Retinol has more extensive clinical evidence for wrinkle reduction, while GHK-Cu and SNAP-8 are described as promising developments in cosmetic skincare research. - The serum comes in a 40 mL, or 1.35 fl oz, size. - The recommended retail price is A$129.
Between the lines: - Myburgh & Co is leaning into a familiar consumer tradeoff in skincare: strong anti-ageing claims paired with a formula positioned for those who want to avoid retinol-related dryness, redness, peeling and irritation. - The launch signals how peptide ingredients are moving from niche cosmetic science into mainstream marketing and product strategy. - The messaging frames peptides not as a replacement for retinol’s evidence base, but as a different path for consumers with sensitive skin or ingredient preferences.
What's next: - Myburgh & Co says the launch is part of its developing range of premium skincare products. - The company is signaling a broader push into advanced peptide skincare as consumer interest in these ingredients grows. - Consumers can explore the brand's skincare collection online through the company website and social channels.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Australian Healthcare Herald
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.